V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260012971 | 260008069 | 1.62 | 81.5 | Palliative (P) | 2014-02-19 | 2014-04-03 | BEP 3 day | 2 | N | 260025085 | BEP |
| 260012972 | 260008070 | 1.67 | 56.2 | Palliative (P) | 2014-09-01 | 2014-09-06 | BEP 5 Day | N | N | 260025093 | BEP |
| 260012973 | 260013773 | 1.7 | 58.9 | null | 2016-07-29 | 2016-08-04 | BEP 3 day | 2 | N | 260025094 | BEP |
| 260012974 | 260013773 | 1.7 | 80.2 | Palliative (P) | 2015-03-19 | 2015-03-25 | BEP 3 day | 2 | N | 260025094 | BEP |
| 260012975 | 260008071 | 1.58 | 68.7 | Palliative (P) | 2016-11-22 | 2016-11-22 | Bendamustine+Rituximab(Sub Courses) | 2 | null | 260025097 | BENDAMUSTINE + RITUXIMAB |
| 260012976 | 260008072 | 1.5 | 71.7 | null | 2013-06-03 | 2013-08-25 | BEP 5 Day | 2 | N | 260025099 | BEP |
| 260012977 | 260008073 | 1.7 | 51.4 | Palliative (P) | 2017-10-04 | 2017-10-11 | Bendamustine+Rituximab(Sub Courses) | 02 | null | 260025100 | BENDAMUSTINE + RITUXIMAB |
| 260012978 | 260008073 | 1.8 | 99.3 | Palliative (P) | 2018-09-15 | 2018-09-22 | Bendamustine+Rituximab (1st Course) | N | N | 260025100 | BENDAMUSTINE + RITUXIMAB |
| 260012979 | 260008073 | 1.95 | null | Adjuvant (A) | null | 2018-11-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025100 | BENDAMUSTINE + RITUXIMAB |
| 260012980 | 260008076 | 1.79 | 63 | Neo-adjuvant (N) | 2014-03-01 | 2014-03-15 | BEP 3 day | 02 | N | 260025108 | BEP |
| 260012981 | 260013776 | 1.8 | 69 | Curative (C) | 2017-12-17 | 2018-01-15 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025110 | BENDAMUSTINE + RITUXIMAB |
| 260012984 | 260019036 | 1.72 | 79 | Curative (C) | 2016-03-27 | 2016-04-02 | BEP 5 Day | 2 | N | 260025118 | BEP |
| 260012985 | 260016586 | 1.68 | 72 | Palliative (P) | 2017-06-07 | 2017-06-09 | BEP 5 Day | 2 | N | 260025118 | BEP |
| 260012986 | 260008079 | 1.74 | 52.9 | null | 2015-05-04 | 2015-05-16 | BENDAMUSTINE + RITUXIMAB | N | null | 260025120 | BENDAMUSTINE + RITUXIMAB |
| 260012987 | 260008079 | 1.74 | 81 | Not known (9) | null | 2016-07-26 | BEP 5 Day | N | N | 260025120 | BEP |
| 260012988 | 260013780 | 1.74 | 74.7 | Palliative (P) | 2013-06-16 | 2013-06-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025128 | BENDAMUSTINE + RITUXIMAB |
| 260012989 | 260016588 | null | null | Palliative (P) | 2013-05-09 | 2013-08-10 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025129 | BENDAMUSTINE + RITUXIMAB |
| 260012990 | 260008081 | 1.57 | 85.7 | Palliative (P) | 2013-10-24 | 2013-10-26 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025130 | BENDAMUSTINE + RITUXIMAB |
| 260012991 | 260013781 | 1.67 | 103 | Palliative (P) | 2015-12-11 | 2015-12-26 | BEP 3 day | N | N | 260025130 | BEP |
| 260012992 | 260008082 | 1.7 | 93.9 | Curative (C) | 2018-01-24 | 2018-02-21 | BEP 5 Day | N | N | 260025133 | BEP |
| 260012993 | 260013782 | 1.7 | 83 | Disease modification (D) | 2015-02-05 | 2015-02-12 | BEP 3 day | N | N | 260025134 | BEP |
| 260012994 | 260013782 | null | 79.5 | Curative (C) | 2014-03-18 | 2014-03-18 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025134 | BENDAMUSTINE + RITUXIMAB |
| 260012995 | 260013782 | 1.67 | 72.2 | Curative (C) | 2016-07-02 | 2016-08-15 | BEP 3 day | 02 | N | 260025134 | BEP |
| 260012996 | 260013782 | 1.56 | 89.6 | Palliative (P) | 2014-03-25 | 2014-04-02 | BEP 3 day | N | N | 260025134 | BEP |
| 260012997 | 260013782 | 1.8 | null | Curative (C) | 2015-02-21 | 2015-03-12 | BEP 3 day | 2 | N | 260025134 | BEP |
| 260012998 | 260008083 | 1.81 | 61 | Not known (9) | null | 2016-01-22 | BEP 5 Day | 02 | N | 260025148 | BEP |
| 260012999 | 260008084 | 1.53 | 67.8 | Curative (C) | 2017-07-13 | 2017-07-13 | BEP 5 Day | 02 | N | 260025152 | BEP |
| 260013000 | 260008085 | null | 98 | Palliative (P) | 2016-06-19 | 2016-07-05 | BENDAMUSTINE + RITUXIMAB | N | N | 260025155 | BENDAMUSTINE + RITUXIMAB |
| 260013001 | 260008085 | 1.82 | 66 | Palliative (P) | 2017-10-28 | 2017-11-02 | BEP 3 day | N | N | 260025155 | BEP |
| 260013002 | 260008085 | 1.79 | 105.4 | Disease modification (D) | 2014-07-25 | 2014-07-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025155 | BENDAMUSTINE + RITUXIMAB |
| 260013003 | 260008086 | null | null | null | 2014-12-03 | 2014-12-08 | BEP 3 day | N | null | 260025164 | BEP |
| 260013004 | 260008087 | 1.54 | 74 | Adjuvant (A) | 2015-03-17 | 2015-03-17 | BEP 5 Day | N | N | 260025167 | BEP |
| 260013005 | 260008088 | 1.74 | 108.299 | Curative (C) | 2017-12-10 | 2018-01-13 | Bendamustine+Rituximab(Sub Courses) | 02 | null | 260025170 | BENDAMUSTINE + RITUXIMAB |
| 260013006 | 260008089 | 1.67 | 90 | Curative (C) | 2015-04-11 | 2015-05-17 | BEP 5 Day | 02 | N | 260025170 | BEP |
| 260013007 | 260008090 | 1.83 | 97 | Palliative (P) | 2015-10-05 | 2015-10-05 | BEP 3 day | 2 | N | 260025178 | BEP |
| 260013008 | 260008090 | 1.87 | 122.5 | Palliative (P) | 2017-05-10 | 2017-06-03 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025178 | BENDAMUSTINE + RITUXIMAB |
| 260013009 | 260013787 | 1.78 | 86.9 | Neo-adjuvant (N) | 2014-01-18 | 2014-03-30 | BEP 5 Day | 02 | N | 260025180 | BEP |
| 260013010 | 260008092 | 1.85 | 101 | Disease modification (D) | 2017-03-16 | 2017-04-28 | BENDAMUSTINE + RITUXIMAB | N | N | 260025180 | BENDAMUSTINE + RITUXIMAB |
| 260013011 | 260008094 | 1.8 | 61.1 | Curative (C) | 2013-12-01 | 2013-12-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260025182 | BENDAMUSTINE + RITUXIMAB |
| 260013012 | 260008097 | 1.76 | 86.8 | Palliative (P) | 2015-10-24 | 2015-10-27 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025186 | BENDAMUSTINE + RITUXIMAB |
| 260013013 | 260013791 | 1.73 | 53 | Curative (C) | 2015-04-27 | 2015-05-10 | BEP 5 Day | 02 | N | 260025186 | BEP |
| 260013014 | 260008098 | 1.55 | 91.8 | Palliative (P) | 2018-07-19 | 2018-08-10 | BEP 3 day | N | N | 260025194 | BEP |
| 260013015 | 260008098 | 1.7 | 52.1 | Curative (C) | 2013-09-16 | 2013-09-19 | BEP 3 day | 2 | N | 260025194 | BEP |
| 260013016 | 260008099 | 1.74 | 94 | Curative (C) | 2017-04-16 | 2017-05-16 | BEP 3 day | 02 | N | 260025200 | BEP |
| 260013017 | 260008099 | 0 | 82 | Palliative (P) | 2018-08-25 | 2018-09-05 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025200 | BENDAMUSTINE + RITUXIMAB |
| 260013018 | 260008099 | 1.79 | 83 | Disease modification (D) | 2013-04-11 | 2013-04-18 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025200 | BENDAMUSTINE + RITUXIMAB |
| 260013019 | 260008100 | 1.77 | null | Curative (C) | 2019-01-05 | 2019-02-07 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025204 | BENDAMUSTINE + RITUXIMAB |
| 260013020 | 260008101 | 1.78 | null | null | 2015-09-14 | 2015-10-22 | BENDAMUSTINE + RITUXIMAB | N | N | 260025205 | BENDAMUSTINE + RITUXIMAB |
| 260013021 | 260008102 | 1.86 | 52.6 | Disease modification (D) | 2018-01-28 | 2018-01-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025205 | BENDAMUSTINE + RITUXIMAB |
| 260013022 | 260008102 | 1.79 | 67.5 | Palliative (P) | 2017-09-30 | 2017-10-09 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025205 | BENDAMUSTINE + RITUXIMAB |